Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Other Non-Current Liabilities (2016 - 2025)

Lineage Cell Therapeutics' Other Non-Current Liabilities history spans 16 years, with the latest figure at $43.9 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 612.64% year-over-year to $43.9 million; the TTM value through Dec 2025 reached $43.9 million, up 612.64%, while the annual FY2025 figure was $43.9 million, 612.64% up from the prior year.
  • Other Non-Current Liabilities reached $43.9 million in Q4 2025 per LCTX's latest filing, down from $45.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $45.2 million in Q3 2025 to a low of $1000.0 in Q1 2023.
  • Average Other Non-Current Liabilities over 5 years is $8.6 million, with a median of $34500.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 98.8% in 2022, then soared 612.64% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $30000.0 in 2021, then crashed by 93.33% to $2000.0 in 2022, then crashed by 50.0% to $1000.0 in 2023, then soared by 616000.0% to $6.2 million in 2024, then skyrocketed by 612.64% to $43.9 million in 2025.
  • Per Business Quant, the three most recent readings for LCTX's Other Non-Current Liabilities are $43.9 million (Q4 2025), $45.2 million (Q3 2025), and $18.8 million (Q2 2025).